Of the two pathways identified as potential prognostic biomarkers of ESCC, the Keap1-Nrf2 pathway is known for inducing chemoradioresistance (Taguchi and Yamamoto, 2017; Zhang et al., 2018). This evidence concerns the gene NFE2L2 and esophageal squamous cell carcinoma.